Pharmaceutical Technology BioPharm - February 2025

Pharmaceutical Technology BioPharm - February 2025

Issue link: https://www.e-digitaleditions.com/i/1532595

Contents of this Issue

Navigation

Page 16 of 27

PHARMACEUTICAL SERVICES GXP ANALYSIS & DEVELOPMENT EXPERTISE Your partner for regulatory-driven, phase-appropriate analytical programs tailored to your product. We offer Total Quality Assurance expertise, helping you to navigate the challenges of development, regulatory submission, and production. BIOLOGICS | CELL & GENE THERAPIES | DNA | RNA | VACCINES • Experienced GLP/GCP and GMP laboratory services outsourcing partner • Global drug delivery expertise • Inhaled and nasal drug product development • Structural characterisation and physicochemical properties (ICH Q6B) • Clinical / preclinical bioanalysis (PK, ADA, Nab) and biomarker solutions • Method development / validation and GMP analysis • Comparability / biosimilar studies • ATMP analytical and CMC support • Cell based potency assays • ICH stability programs • Extractables / Leachables biopharma@intertek.com +44 (0)116 296 1620 intertek.com/pharmaceutical/biopharmaceuticals 25-26 SEPTEMBER, 2025 | CAMBRIDGE, UK Join us for a ground-breaking and insightful forum on inhaled and nasal biologics development. Don't miss the opportunity to hear from world-renowned industry leaders sharing the latest learnings on inhaled & nasal biologics and DNA medicine development. Stay tuned, we will be releasing more news of our esteemed speakers over the coming months. CONFERENCE PARTNER Find out more online

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology BioPharm - February 2025 - Pharmaceutical Technology BioPharm - February 2025